[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Eskisehir Osmangazi University\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":301},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,10,0,[8,45,75,102,135,162,194,218,250,277],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":31,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100642380","the-effect-of-intravenous-dexketoprofen-on-the-severity-and-incidence-of-rebound-pain-100642380",false,"NCT07642674","The Effect of Intravenous Dexketoprofen on the Severity and Incidence of Rebound Pain","Evaluation of the Effect of Intravenous Dexketoprofen on the Severity and Incidence of Rebound Pain in Patients Undergoing Interscalene Brachial Plexus Block","Inclusion Criteria:\n\nAge 18-70 years ASA score of I-III Arthroscopic shoulder surgery\n\nExclusion Criteria:\n\nPatients who do not wish to participate in the study Creatinine clearance \\\u003C50 mL\u002F min Patients for whom NSAID use is contraindicated due to heart failure, Patients with psychiatric or cognitive dysfunction that would impair their ability to assess visual analog scale (VAS) pain scores Patients for whom peripheral nerve block is contraindicated","ALL","18 Years","70 Years",{"count":20,"type":21},66,"ESTIMATED","INTERVENTIONAL",[24],"NA","Orthopedic shoulder surgeries are associated with severe postoperative pain, particularly within the first 24-48 hours after surgery. In postoperative pain management, single or continue interscalene brachial plexus blocks, acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioids administered as needed are commonly used as components of multimodal analgesia.\n\nRebound pain is defined as severe postoperative pain (VAS ≥ 7) occurring within the first 24 hours after resolution of the block. It is considered an adverse effect of regional anesthesia and typically develops 8-12 hours after a single-shot nerve block. Risk factors for rebound pain include pre-existing pain, female sex, younger age, bone surgery, lack of intraoperative dexamethasone administration, and inadequate analgesia.\n\nThe primary objective of this study is to evaluate the effect of intravenous dexketoprofen administered during the postoperative period on the incidence and severity of rebound pain in patients undergoing shoulder surgery with interscalene brachial plexus block",[27,28,29,30],"Postoperative Pain","Pain Management","Rebound Pain","Interscalene Block",[32],"Rebaund pain, Interscalene block, postoperative pain","RECRUITING","2026-06-11",{"date":36,"type":37},"2026-06-12","ACTUAL",{"date":34,"type":37},{"date":40,"type":21},"2027-01-01",{"name":42,"class":43},"Eskisehir Osmangazi University","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":52,"sex":16,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":4,"studyType":22,"phases":57,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":44},"100637760","avatar-based-education-and-counseling-for-spousal-support-during-menopause-100637760","NCT07599319","Avatar-Based Education and Counseling for Spousal Support During Menopause","Effect of an Avatar-Based Education and Counseling Program on Spousal Support During Menopause","Inclusion Criteria:\n\n* Women aged between 45 and 60 years\n* Being in the menopausal period\n* Married and living with their spouse\n* Able to speak, read, and write in Turkish\n* Able to communicate effectively\n* Willing to participate in the study\n* Having a spouse who is willing to participate\n* Spouses who have internet access and are able to use digital devices\n\nExclusion Criteria:\n\n* Women or their spouses with uncontrolled psychiatric disorders requiring treatment\n* Women whose spouses have serious physical or mental health problems that may prevent providing support\n* Women who experienced early menopause (before age 45)\n* Couples who are married but not living together\n* Women and their spouses who participated in the first (qualitative) phase of the study",true,"45 Years","60 Years",{"count":56,"type":21},280,[24],"This study aims to evaluate the effectiveness of an avatar-based education and counseling program in increasing spousal support during menopause. The study will include menopausal women and their spouses. Participants will be assigned to intervention and control groups. The intervention group will receive a structured online avatar-based education and counseling program, while the control group will receive routine care. Outcomes will be assessed before and after the intervention, as well as during follow-up periods.",[60],"Menopause",[62,63,64,65,66],"Spousal Support","Education","Menopause Education","Counseling","Avatar-Based Intervention","2026-05-14",{"date":69,"type":37},"2026-05-20",{"date":71,"type":37},"2025-07-15",{"date":73,"type":21},"2027-03-15",{"name":42,"class":43},{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":81,"eligibilityCriteria":82,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":83,"enrollmentInfo":84,"targetDuration":4,"studyType":86,"phases":4,"briefSummary":87,"conditions":88,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":44},"100629414","gender-differences-in-depression-severity-gender-sensitive-symptoms-resilience-and-stigma-in-major-depressive-disorder-100629414","NCT07474363","Gender Differences in Depression Severity, Gender-Sensitive Symptoms, Resilience, and Stigma in Major Depressive Disorder","A Comparative Examination of Depression Severity, Gender-Sensitive Depressive Symptoms, Psychological Resilience, and Stigma Levels in Women and Men With Major Depressive Disorder","GD-GSS-R-S-MDD","Inclusion Criteria:\n\n* Male and female patients aged 18 to 65 years\n* Diagnosis of Major Depressive Disorder according to DSM-5 at the time of study participation\n* Provision of voluntary informed consent\n\nExclusion Criteria:\n\n* Intellectual disability\n* Severe neurological disorders\n* Comorbid psychiatric diagnoses\n* Depressive disorder secondary to an organic medical condition\n* Depressive disorder secondary to substance use","65 Years",{"count":85,"type":21},90,"OBSERVATIONAL","Depression is a common and serious mental health condition that affects mood, thoughts, behavior, and overall quality of life. It arises from a complex interaction of biological, psychological, and environmental factors. While depression is more frequently diagnosed in women, research suggests that men may experience and express depressive symptoms differently. Men are more likely to display symptoms such as irritability, anger, impulsivity, or increased alcohol use, and they may be less likely to seek professional psychological support due to social expectations and fear of stigma.\n\nStigma-both self-stigma (internalized negative beliefs about having a mental illness) and perceived social stigma (concerns about being judged by others)-can negatively influence individuals' willingness to seek help and adhere to treatment. In addition, psychological resilience, defined as the ability to cope effectively with stress and adversity, may play an important role in how individuals experience depressive symptoms and respond to treatment.\n\nThis study aims to compare women and men diagnosed with Major Depressive Disorder in terms of depression severity, gender-sensitive depressive symptoms, self-stigma, perceived social stigma, and levels of psychological resilience. It will also examine the relationships among these factors to better understand how gender-related differences influence the experience and management of depression.\n\nFindings from this study may contribute to improved recognition of gender-specific features of depression, reduction of stigma, and the development of more individualized and effective mental health interventions for both women and men.",[89,90,91,92,93],"Major Depressive Disorder (MDD)","Gender Differences","Resilience, Psychological","Self Stigma","Social Stigma","2026-03-23",{"date":96,"type":37},"2026-03-25",{"date":98,"type":37},"2025-06-01",{"date":100,"type":21},"2026-11",{"name":42,"class":43},{"id":103,"slug":104,"hasResults":11,"nctId":105,"briefTitle":106,"officialTitle":107,"acronym":108,"eligibilityCriteria":109,"healthyVolunteers":11,"sex":16,"minAge":110,"maxAge":111,"enrollmentInfo":112,"targetDuration":114,"studyType":86,"phases":4,"briefSummary":115,"conditions":116,"keywords":121,"overallStatus":126,"whyStopped":4,"lastUpdateSubmitDate":127,"lastUpdatePostDateStruct":128,"startDateStruct":130,"completionDateStruct":132,"leadSponsor":134,"locationsCount":4},"100619618","rsv-positive-children-5-years-presenting-to-pediatric-emergency-departments-in-trkiye-trust-rsv-100619618","NCT07346963","RSV-Positive Children \u003C5 Years Presenting to Pediatric Emergency Departments in Türkiye: TRUST-RSV","Evaluation of Demographic, Clinical, and Healthcare Utilization Characteristics of Respiratory Syncytial Virus (RSV) Positive Cases Under 5 Years Presenting to Pediatric Emergency Departments in Türkiye: A Multicenter, Prospective Observational Study (TRUST-RSV)","TRUST-RSV","Inclusion Criteria:\n\n* Age \\\u003C5 years at presentation\n* Presentation during RSV season (2025-2026 )\n* RSV infection confirmed from a nasopharyngeal sample by rapid antigen test or PCR according to site capacity\n* Presentation to a participating pediatric ED with at least one of the following clinical diagnoses: upper respiratory tract infection, bronchiolitis, pneumonia, apnea, seizure\u002Fconvulsion, or myocarditis\n* Written informed consent obtained from a parent or legal guardian.\n\nExclusion Criteria:\n\n* Parent or legal guardian declines consent","28 Days","5 Years",{"count":113,"type":21},4000,"30 Days","Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infection in infants and young children and contributes substantially to pediatric emergency department (ED) visits and hospitalizations. In Türkiye, nationally representative prospective data describing the epidemiology, clinical spectrum, and resource utilization of RSV-positive children presenting to pediatric EDs remain limited. This multicenter prospective observational study aims to characterize demographic and clinical features of RSV-positive children under 5 years of age presenting to participating pediatric EDs across two consecutive RSV seasons, and to quantify key healthcare utilization outcomes, including ED observation duration, hospitalization, and intensive care unit (ICU) admission.",[117,118,119,120],"Respiratory Syncytial Virus Infection","Acute Bronchiolitis Due to Respiratory Syncytial Virus","Pneumonia","Upper Respiratory Tract Infection",[122,123,124,125],"pediatric emergency department","multicenter","prospective","healthcare utilization","NOT_YET_RECRUITING","2026-01-08",{"date":129,"type":37},"2026-01-16",{"date":131,"type":21},"2026-01-01",{"date":133,"type":21},"2027-06-01",{"name":42,"class":43},{"id":136,"slug":137,"hasResults":11,"nctId":138,"briefTitle":139,"officialTitle":140,"acronym":141,"eligibilityCriteria":142,"healthyVolunteers":11,"sex":16,"minAge":143,"maxAge":144,"enrollmentInfo":145,"targetDuration":4,"studyType":22,"phases":147,"briefSummary":148,"conditions":149,"keywords":151,"overallStatus":126,"whyStopped":4,"lastUpdateSubmitDate":155,"lastUpdatePostDateStruct":156,"startDateStruct":158,"completionDateStruct":159,"leadSponsor":161,"locationsCount":4},"100619244","evaluating-the-lgg-of-on-acute-infectious-diarrhea-in-children-100619244","NCT07342101","Evaluating the LGG of on Acute Infectious Diarrhea in Children","A Multicenter, Prospective, Randomized, Double-Blind, Open-Label Clinical Trial Evaluating the Effects of Lacticaseibacillus Rhamnosus GG on Acute Infectious Diarrhea in Children in Türkiye","PROBAGE 2","Inclusion Criteria:\n\n* Children aged 1 month to 10 years presenting with acute infectious diarrhea (for S. boulardii group)\n* Children aged 2 to 10 years presenting with acute infectious diarrhea (other probiotics or synbiotics groups)\n* Onset of diarrhea symptoms within the last 48 hours.\n* Parental\u002Flegal guardian consent obtained.\n\nExclusion Criteria:\n\n* Use of any probiotics or biotic formulations within the past 8 weeks.\n* Use of antibiotics in the last 8 weeks.\n* Presence of chronic diseases (e.g., diabetes, congenital heart disease, immunodeficiencies).\n* Previous gastrointestinal surgical procedures.","2 Years","10 Years",{"count":146,"type":21},480,[24],"Acute diarrhea due to infectious causes is a major source of morbidity in the pediatric population.\n\nAlthough it is generally self-limiting, acute diarrhea may lead to severe dehydration, hospitalization, and, rarely, death, particularly in young children. Numerous studies have investigated the role of probiotics and other microbiota-targeted therapies in improving the clinical course of infectious acute diarrhea.\n\nThe first multicenter PROBAGE study conducted in Türkiye 15 years ago provided valuable evidence regarding the efficacy of probiotics in this context. Over the past 15 years, changes in epidemiology-especially in the post-pandemic period-have created a need for new studies evaluating the effectiveness of probiotics in acute diarrhea.\n\nThe PROBAGE 2.0.1 study is designed to evaluate the efficacy of Lactobacillus rhamnosus GG in the treatment of acute infectious diarrhea in children in Türkiye. This is a multicenter, prospective, randomized, open-label, controlled clinical trial, to be conducted across seven tertiary care medical centers nationwide. A total of 480 children with acute infectious diarrhea will be enrolled.\n\nAt the initial presentation, stool samples will be collected to identify rotavirus, norovirus, and adenovirus as causative pathogens. The treatment group (n = 240) will receive standard of care plus Lactobacillus rhamnosus GG (one sachet twice daily for 5 or 10 days), whereas the control group (n = 240) will receive standard of care alone.\n\nDaily monitoring of stool frequency and consistency will be documented for 10 days, by families for outpatients and by physicians and nurses for hospitalized patients. Provided that sufficient data are obtained, data analysis and publication phases will be completed.",[150],"Acute Infectious Diarrhoea in Children",[152,153,154],"probiotic","diarrhea","LGG","2026-01-06",{"date":157,"type":37},"2026-01-15",{"date":131,"type":21},{"date":160,"type":21},"2027-12-31",{"name":42,"class":43},{"id":163,"slug":164,"hasResults":11,"nctId":165,"briefTitle":166,"officialTitle":166,"acronym":167,"eligibilityCriteria":168,"healthyVolunteers":11,"sex":169,"minAge":170,"maxAge":54,"enrollmentInfo":171,"targetDuration":173,"studyType":86,"phases":4,"briefSummary":174,"conditions":175,"keywords":179,"overallStatus":126,"whyStopped":4,"lastUpdateSubmitDate":186,"lastUpdatePostDateStruct":187,"startDateStruct":189,"completionDateStruct":191,"leadSponsor":193,"locationsCount":44},"100612895","escitalopram-plasma-concentrations-in-premenopausal-and-postmenopausal-women-100612895","NCT07259525","Escitalopram Plasma Concentrations in Premenopausal and Postmenopausal Women","MENO-ES","Inclusion Criteria:\n\n* Aged 40 years or older and 60 years or younger\n* Diagnosed with major depressive disorder and\u002For generalized anxiety disorder by an independent psychiatrist (not a member of the research team)\n* Prescribed escitalopram treatment by an independent psychiatrist (not a member of the research team)\n* Receiving escitalopram treatment for at least one month and on a stable dose for at least one week\n* Willing to participate in the study and provide informed consent\n* Additional inclusion criterion for the menopausal group: Amenorrhea for at least one year (consistent with menopause diagnosis)\n* Additional inclusion criteria for the premenopausal group: Having regular menstrual cycles and being in the luteal phase (within 14 days after ovulation) of the menstrual cycle\n\nExclusion Criteria:\n\n* Diagnosis of intellectual disability, dementia, psychotic disorders, schizoaffective disorder, or bipolar disorder\n* Alcohol or substance use disorder\n* Diagnosis of hepatic failure, renal failure, or cardiac failure\n* Severe malnutrition\n* Presence of an active systemic infectious or inflammatory disease\n* Current use of hormone replacement therapy for menopause\n* Use of oral contraceptives\n* Pregnancy or breastfeeding\n* Use of medications known to affect escitalopram plasma concentration\n* Use of medications that affect the CYP2C19 enzyme\n* Detection of alleles other than the predominant CYP2C19\\*1 genotype in genetic analyses","FEMALE","40 Years",{"count":172,"type":21},94,"14 Days","This observational cross-sectional case-control study aims to evaluate the effects of menopausal status on escitalopram metabolism in women. The study will include premenopausal and menopausal women aged 40-60 years who are currently receiving escitalopram treatment and have applied to the Psychiatry Clinic of Eskişehir Osmangazi University. The study aims to identify pharmacokinetic differences associated with hormonal status and to investigate their potential clinical implications. Findings from this research are expected to contribute to the development of evidence-based, individualized treatment strategies for women in menopausal transition.",[176,60,177,178],"Therapeutic Drug Monitoring (TDM)","Depression - Major Depressive Disorder","General Anxiety Disorder",[180,181,182,183,184,185],"escitalopram","desmethylescitalopram","menopause","therapeutic drug monitoring","major depressive disorder","general anxiety disorder","2025-12-16",{"date":188,"type":37},"2025-12-22",{"date":190,"type":21},"2026-01",{"date":192,"type":21},"2028-06",{"name":42,"class":43},{"id":195,"slug":196,"hasResults":11,"nctId":197,"briefTitle":198,"officialTitle":199,"acronym":4,"eligibilityCriteria":200,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":201,"enrollmentInfo":202,"targetDuration":4,"studyType":22,"phases":204,"briefSummary":205,"conditions":206,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":210,"lastUpdatePostDateStruct":211,"startDateStruct":213,"completionDateStruct":215,"leadSponsor":217,"locationsCount":44},"100610552","the-effect-of-video-based-education-on-colonoscopy-preparation-100610552","NCT07229066","The Effect of Video-Based Education on Colonoscopy Preparation","Evaluation of the Effect of Video-Based Education on Bowel Preparation Before Colonoscopy","Inclusion Criteria:\n\n* Voluntary participation in the study.\n* Outpatient follow-up.\n* No prior history of colonoscopy.\n* Participant or a household member (spouse, child, parent, sibling) owns and can use a smartphone application.\n\nExclusion Criteria:\n\n* History of major abdominal surgery.\n* Suspected obstructive lesion in the gastrointestinal tract on cross-sectional imaging.\n* Impaired swallowing reflex.\n* Mental disorder.\n* Communication difficulties (speech, perception, comprehension problems).\n* Congestive heart failure or kidney failure.\n* Pregnancy or breastfeeding.","80 Years",{"count":203,"type":21},246,[24],"Colonoscopy is a routine procedure for evaluating gastrointestinal symptoms, detecting colorectal cancer, and removing polyps. Its effectiveness depends on patient compliance with bowel preparation instructions. However, inadequate bowel preparation occurs in 20-25% of colonoscopies, often due to non-adherence, medical conditions, or long waiting times. Poor preparation can reduce examination quality, prevent detection of precancerous lesions, and increase healthcare costs. Video-based education has been shown to be more effective than written or verbal instructions in improving bowel preparation. This study aims to evaluate the effect of video-based education on colonoscopy bowel preparation and contribute evidence to optimize patient compliance.",[207,208,209],"Bowel Preparation Quality","Colonoscopy","Patient Education","2025-11-13",{"date":212,"type":37},"2025-11-14",{"date":214,"type":37},"2024-06-01",{"date":216,"type":21},"2026-03-30",{"name":42,"class":43},{"id":219,"slug":220,"hasResults":11,"nctId":221,"briefTitle":222,"officialTitle":223,"acronym":4,"eligibilityCriteria":224,"healthyVolunteers":11,"sex":16,"minAge":225,"maxAge":17,"enrollmentInfo":226,"targetDuration":4,"studyType":22,"phases":228,"briefSummary":229,"conditions":230,"keywords":236,"overallStatus":126,"whyStopped":4,"lastUpdateSubmitDate":210,"lastUpdatePostDateStruct":244,"startDateStruct":245,"completionDateStruct":247,"leadSponsor":249,"locationsCount":44},"100610511","cesikids-trial-enhancing-psychological-resilience-in-adolescents-with-cancer-100610511","NCT07228533","CesiKids Trial: Enhancing Psychological Resilience in Adolescents With Cancer","Evaluation of the Effectiveness of a Nursing-Based Co-Design Intervention Program (CesiKids) to Enhance Psychological Resilience in Hospitalized Adolescents Diagnosed With Cancer: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Parents have provided informed consent after receiving information,\n* The child has given assent to participate after being informed,\n* The child is between 12 and 18 years of age,\n* The child has been diagnosed with cancer and is currently receiving inpatient treatment,\n* The child is undergoing chemotherapy and\u002For radiotherapy,\n* The child is able to use a computer and\u002For smartphone,\n* The child can understand and speak Turkish.\n\nExclusion Criteria:\n\n* Receiving hematopoietic stem cell transplantation treatment,\n* Having developed a relapse after remission,\n* Experiencing communication difficulties (e.g., intellectual disability, visual impairment, etc.),\n* Having a psychiatric diagnosis made by a psychiatrist,\n* Having experienced a significant life event affecting psychological well-being within the past four weeks (e.g., death, divorce, etc.).","12 Years",{"count":227,"type":21},36,[24],"This study will develop and evaluate a mobile-based co-design intervention (CesiKids) to enhance psychosocial resilience in hospitalized adolescents aged 12-18 diagnosed with cancer. The program will be created using Bronfenbrenner's Ecological Systems Theory and designed in collaboration with nurses, recovered adolescents, and parents. A randomized controlled design will be used. The intervention group will participate in a four-week structured program, while the control group will receive standard care. Psychosocial resilience and coping outcomes will be assessed at baseline, post-intervention, and follow-up. This research aims to offer an evidence-based, scalable model to support resilience among adolescents with cancer in clinical settings.",[91,231,232,233,234,235],"Adolescent Cancer","Mobile Application","Pediatric Cancer","Pediatric Nursing","Coping",[237,238,239,240,241,242,243],"Adolescent","Resilience","Coping skills","Neoplasms","Pediatric nursing","Mobile application","Psychosocial intervention",{"date":212,"type":37},{"date":246,"type":21},"2025-11",{"date":248,"type":21},"2027-06",{"name":42,"class":43},{"id":251,"slug":252,"hasResults":11,"nctId":253,"briefTitle":254,"officialTitle":254,"acronym":255,"eligibilityCriteria":256,"healthyVolunteers":52,"sex":169,"minAge":17,"maxAge":83,"enrollmentInfo":257,"targetDuration":259,"studyType":86,"phases":4,"briefSummary":260,"conditions":261,"keywords":265,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":269,"lastUpdatePostDateStruct":270,"startDateStruct":272,"completionDateStruct":274,"leadSponsor":276,"locationsCount":44},"100603034","evaluating-sexual-functioning-in-trans-men-during-the-gender-affirmation-process-a-mixed-methods-study-100603034","NCT07131267","Evaluating Sexual Functioning in Trans Men During the Gender Affirmation Process: A Mixed Methods Study","ESFTMGAP","Inclusion Criteria:\n\n18 years or older Diagnosed with gender dysphoria by two different physicians Getting medical support for the gender affirmation process\n\nExclusion Criteria:\n\nOver 65 years Diagnosed with intellectual disability, dementia, or organic mental disorders Having a systemic disease that negatively impacts sexual function Getting a score above 3 on the Clinical Global Impression Scale",{"count":258,"type":21},52,"1 Day","Both sexual experiences and the process of gender transition initiated to reduce gender dysphoria carry cultural characteristics. Gender categories, societal expectations for each gender, and attitudes toward sexual minorities in a given society can shape the lived experiences of trans individuals. Therefore, research on individuals with gender dysphoria in different cultural contexts is of great importance. To our knowledge, no study in Türkiye has examined sexual functioning in trans individuals undergoing gender transition. For this reason, our study aimed to investigate how sexual functioning is affected by the gender transition process in trans men with gender dysphoria, using both quantitative and qualitative methods.",[262,263,264],"Sexual Functioning","Transgender Men","Gender Affirmation Surgery",[266,267,268],"sexual functioning","transgender men","gender affirmation","2025-08-19",{"date":271,"type":37},"2025-08-20",{"date":273,"type":37},"2025-08-05",{"date":275,"type":21},"2026-12-31",{"name":42,"class":43},{"id":278,"slug":279,"hasResults":11,"nctId":280,"briefTitle":281,"officialTitle":281,"acronym":4,"eligibilityCriteria":282,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":283,"targetDuration":4,"studyType":22,"phases":285,"briefSummary":286,"conditions":287,"keywords":289,"overallStatus":126,"whyStopped":4,"lastUpdateSubmitDate":293,"lastUpdatePostDateStruct":294,"startDateStruct":296,"completionDateStruct":298,"leadSponsor":300,"locationsCount":44},"100568215","the-effect-of-the-mobile-game-ask-olsun-on-the-development-of-young-adults-attitudes-and-perceptions-towards-dating-violence-a-randomized-controlled-study-100568215","NCT06678321","THE EFFECT OF THE MOBILE GAME \"ASK OLSUN!\" ON THE DEVELOPMENT OF YOUNG ADULTS' ATTITUDES AND PERCEPTIONS TOWARDS DATING VIOLENCE: A RANDOMIZED CONTROLLED STUDY\"","Inclusion Criteria:\n\n* Having at least one dating relationship\n* Being exposed to dating violence (any type) at least once in a dating relationship\n* Be single\n\nExclusion Criteria:\n\n* Married\n* Have never been in a dating relationship\n* Not having experienced dating violence in any way\n* Not volunteering to participate in the research",{"count":284,"type":21},134,[24],"This research; It was designed as a 3-stage study with the aim of evaluating the mobile game that will be developed to positively change the attitudes and perceptions of young people studying at Istanbul Bilgi University towards dating violence. The first phase of the research was designed in a cross-sectional pattern to determine young people's general attitudes towards dating violence and their perceptions towards dating violence. The second phase of the study was designed in a methodological pattern to include the development of a mobile game to positively change young people's general attitudes and perceptions towards dating violence and increase their awareness. The third phase of the study was designed with a randomized controlled experimental design to determine the effect of the developed mobile game on young people's general attitudes towards dating violence and their perceptions towards dating violence. In the study, \"Socio-demographic Characteristics and Data Form\" created by the researcher will be used to collect data, \"Flirting Violence Attitude Scale\" will be used to determine the general attitude towards dating violence, and \"Flirting Violence Perception Scale\" will be used to determine the perception of dating violence. \"Socio-demographic Data Form\", Dating Violence Attitude Scale and Dating Violence Perception Scale will be used in the second stage of the study to recruit participants to the study groups. Research data will be collected online by the researcher via Google surveys after the participants are informed about the research and their consent is obtained.\n\nIn the third stage of the study, data will be collected in two separate processes: pre-test and post-test. The pre-test consists of the Sociodemographic Characteristics and Data Form, the Dating Violence Attitude Scale and the Dating Violence Perception Scale. The pre-test will be administered after oral and written consent of the participants included in the intervention and control groups is obtained.\n\nIn the last test; The Dating Violence Attitude Scale and the Dating Violence Perception Scale will be used. The post-test will be administered after oral and written consent of the participants included in the study groups is obtained.\n\nA mobile game consisting of 8 episodes within the scope of dating violence based on the health belief model will be played to the intervention group and the final test will be applied to the same group 4 weeks later. There will be no intervention in the control group, and the final test will be administered 4 weeks later.",[288],"Dating Violence",[290,291,292],"dating violence","mobil game","university students","2024-11-06",{"date":295,"type":37},"2024-11-07",{"date":297,"type":21},"2024-11-20",{"date":299,"type":21},"2025-06-20",{"name":42,"class":43},""]